方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 甲状腺眼病生活质量问卷 / Graves眼病生活质量问卷× | ThyPRO：甲状腺相关患者报告结局量表× | |
|---|---|---|
| 领域 | 内分泌学 | 内分泌学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2001 | 2009 |
| 提出者≠ | Caroline Terwee, Markus Gerding, Frank Dekker | Torquil Watt, Jens Bjørner, Marianne Groenvold |
| 类型 | Patient self-report questionnaire | Patient self-report questionnaire |
| 开创性文献≠ | Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779. link ↗ | Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580. link ↗ |
| 别名 | GO-QoL, Graves Ophthalmopathy Quality of Life | ThyPRO-85, ThyPRO-39 |
| 相关 | 3 | 3 |
| 摘要≠ | The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment. | ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer. |
| ScholarGate数据集 ↗ |
|
|